Annual Information Update

RNS Number : 5056B

Oxford Biomedica PLC

17 April 2012

Oxford BioMedica plc ("Oxford BioMedica" or the "Company")

Annual Information Update for the Twelve Months to 1 April 2012

Oxford BioMedica is providing an annual information update pursuant to Prospectus Rule 5.2 made by the Financial Services Authority.

1. Announcements made via a Regulatory Information Service

Date	Announcement

04 April 2011	Annual Information Update
15 April 2011	Directors' Interest in Shares and Share Options
03 May 2011	Announcement of data in ProSavin^® study
04 May 2011	Pfizer license extension
05 May 2011	Annual General Meeting and Board changes
18 May 2011	Interim management statement
23 May 2011	New clinical data from ProSavin^® Phase I/II study
24 May 2011	Management and Board changes
26 May 2011	Block listing six monthly return
07 June 2011	Research agreement with ImaginAb
28 June 2011	Notice of results
08 July 2011	Holding(s) in Company
04 August 2011	Interim data from ProSavin^® Phase I/II study
31 August 2011	TR-1: Notification of Major Interest in Shares
31 August 2011	Interim Results
04 October 2011	TR1 Form
04 October 2011	TR1 Form
18 October 2011	US IND approval for novel ocular product in Usher syndrome type 1B
16 November 2011	Interim management statement
28 November 2011	Block listing six monthly return
15 December 2011	Interim update on ProSavin^® Phase I/II study
16 December 2011	Directors' interest in shares
30 January 2012	Notification of Major Interest in Shares
10 February 2012	Management and Board change
24 February 2012	Notice of results
06 March 2012	Preliminary results
08 March 2012	Director / PDMR dealings
12 March 2012	Significant shareholding
22 March 2012	TR-1 Notification of Major Interest in Shares

Details of all regulatory announcements for Oxford BioMedica can be found on the London Stock Exchange website at www.londonstockexchange.com and on the Oxford BioMedica website at http://www.oxfordbiomedica.co.uk

2. Documents filed with Companies House

Date	Document type	Description
9 May 2011	RES	Resolution to authorise and allot shares and debentures, to extend share option scheme and to disapply pre-emption rights
11 May 2011	AA	Annual Accounts
29 July 2011	TM01	Termination of appointment, director - Alan Kingsman
29 July 2011	TM01	Termination of appointment, director - Alexander Lewis
27 September 2011	AR01	Annual Return
14 February 2012	TM02	Termination of appointment, secretary - Andrew Wood

Copies of documents filed at Companies House can be obtained from Companies House, Crown Way, Cardiff CF14 3UZ or through Companies House Direct at www.direct.companieshouse.gov.uk

3. Documents published or sent to shareholders or filed with the UKLA National Storage Mechanism

Date	Description
31 August 2011	Interim Report for 6 months to 30 June 2011

Copies of all the above documents may be obtained from the Company Secretary at the Company's Registered Office:

This annual information update is filed pursuant to Prospectus Rule 5.2 made by the Financial Services Authority and not for any other purpose and by filing this annual information update neither the Company, nor any other person, takes any responsibility for, or makes any representation, express or implied, as to the accuracy or completeness of, the information contained or referred to below herein. The information referred to below is not necessarily up to date as at the date of this annual information update and the Company does not undertake any obligation to update any such information in the future. Furthermore, such information may have been prepared in accordance with the laws or regulations of a particular jurisdiction and may not comply with or meet the relevant standards of disclosure in any other jurisdiction. Neither this annual information update, nor the information referred to below constitutes, by virtue of this communication, an offer of any securities addressed to any person and should not be relied on by any person.

Oxford BioMedica plc

Medawar Centre

Robert Robinson Avenue

The Oxford Science Park

Oxford

OX4 4GA

17 April 2012

This information is provided by RNS

The company news service from the London Stock Exchange

END

AIULDLFFLZFEBBZ